2,3,5-TRIDEOXY-N-((1S,2S,3S)-2,3-DIHYDRO-2,3-DIHYDROXY-1H-INDEN-1-YL)-5-((2S)-2-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-4-(3-PYRIDINYLMETHYL)-1-PIPERAZINYL)-2-(PHENYLMETHYL)-D-ERYTHRO-PENTONAMIDE
UNII 9LH7LD8DBC
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,3,5-trideoxy-n-((1s,2s,3s)-2,3-dihydro-2,3-dihydroxy-1h-inden-1-yl)-5-((2s)-2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-d-erythro-pentonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9LH7LD8DBC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 162518-56-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C36H47N5O5 QXNGFJFTQLQPEM-HJNXRVKDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,3,5-trideoxy-n-((1s,2s,3s)-2,3-dihydro-2,3-dihydroxy-1h-inden-1-yl)-5-((2s)-2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-d-erythro-pentonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.